secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2026-08-05T10:32:06+00:00
Accession:  0000064803-26-000097
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q2 2026 GAAP EPS $2.31, adj EPS $2.58; raises FY guidance to $7.90-$8.10 adj EPS
--------------------------------------------------------------------------------

- Total revenues $106.1B, up 7.3% YoY; GAAP diluted EPS $2.31 vs $0.80 prior year.
- Adjusted EPS $2.58 vs $1.81 prior year; Health Care Benefits MBR improved to 87.4% from 89.9%.
- Full-year 2026 guidance raised: GAAP EPS $6.84-$7.04 (from $6.24-$6.44), adj EPS $7.90-$8.10 (from $7.30-$7.50).
- Cash flow from operations guidance raised to at least $11.5B from at least $9.5B; YTD cash flow $10.6B.
- Health Services segment revenue up 11.5% to $51.8B; Pharmacy & Consumer Wellness prescriptions filled up 4.3%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000097/0000064803-26-000097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000097/cvs-20260805.htm
  HTML page:      https://secwatch.observer/filing/0000064803-26-000097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer